NASDAQ:AVEO

Delisted

Aveo Pharmaceuticals Stock News

Healthcare > Biotechnology

Buy AVEO

*Your capital is at risk

$15.00

+0 (+0%)

At Close: Apr 18, 2023

AVEO Pharmaceuticals shares are trading lower after the company announced a regulatory updated for Tivozanib in renal cell carcinoma.

12:00am, Monday, 04'th Nov 2019

AVEO Pharmaceuticals (AVEO) Earnings Expected to Grow: Should You Buy?

12:00am, Friday, 01'st Nov 2019

AVEO Sees Hammer Chart Pattern: Time to Buy?

12:00am, Tuesday, 22'nd Oct 2019

Reata (RETA) Jumps: Stock Rises 5. 6%

12:00am, Thursday, 17'th Oct 2019

AVEO Pharma shares are trading higher. Not seeing any news to justify the price action.

12:00am, Wednesday, 16'th Oct 2019

28 Healthcare Stocks Moving In Friday's Pre-Market Session

12:00am, Friday, 11'th Oct 2019

AVEO Oncology Announces Initiation of Enrollment in Phase 1b/2 Study of FOTIVDA

12:00am, Monday, 30'th Sep 2019

The Week Ahead In Biotech (Sept. 29-Oct. 5): Conference Presentations, IPOs Hit Top Gear

12:00am, Sunday, 29'th Sep 2019

AVEO Oncology Announces Results from its Phase 2 Portion of the TiNivo Study in Renal Cell Carcinoma

12:00am, Monday, 23'rd Sep 2019

24 Healthcare Stocks Moving In Friday's Pre-Market Session

12:00am, Friday, 13'th Sep 2019

28 Healthcare Stocks Moving In Thursday's Pre-Market Session

12:00am, Thursday, 12'th Sep 2019

A Look At Benzinga Pro's Most-Searched Tickers For September 11, 2019

12:00am, Wednesday, 11'th Sep 2019

AVEO Pharmaceuticals shares are trading higher after the company announced an update to the overall survival hazard ratio of 0.99 in Phase 3 trial of its TIVO-3.

Aveo Pharmaceuticals Stock News

AVEO Pharmaceuticals shares are trading lower after the company announced a regulatory updated for Tivozanib in renal cell carcinoma.

AVEO Pharmaceuticals (AVEO) Earnings Expected to Grow: Should You Buy?

AVEO Sees Hammer Chart Pattern: Time to Buy?

Reata (RETA) Jumps: Stock Rises 5. 6%

AVEO Pharma shares are trading higher. Not seeing any news to justify the price action.

28 Healthcare Stocks Moving In Friday's Pre-Market Session

AVEO Oncology Announces Initiation of Enrollment in Phase 1b/2 Study of FOTIVDA

The Week Ahead In Biotech (Sept. 29-Oct. 5): Conference Presentations, IPOs Hit Top Gear

AVEO Oncology Announces Results from its Phase 2 Portion of the TiNivo Study in Renal Cell Carcinoma

24 Healthcare Stocks Moving In Friday's Pre-Market Session

28 Healthcare Stocks Moving In Thursday's Pre-Market Session

A Look At Benzinga Pro's Most-Searched Tickers For September 11, 2019

AVEO Pharmaceuticals shares are trading higher after the company announced an update to the overall survival hazard ratio of 0.99 in Phase 3 trial of its TIVO-3.

AVEO (AVEO) Up 0.2% Since Last Earnings Report: Can It Continue?

Implied Volatility Surging for AVEO Pharmaceuticals (AVEO) Stock Options

Top Fintech Company